Sinopharm Group – World Class Benchmarking
Company: Sinopharm Group Company Limited
Bloomberg ticker: 1099 HK
Market cap: US$4,039m
Background: Sinopharm Group Company Limited is the largest pharmaceutical distributor in China by revenue. It researches and develops, manufactures and markets medicines, ranging from traditional Chinese medicines to prescription and over-the-counter healthcare products and medical devices. The company serves hospitals, clinics, and drug stores.
World Class Benchmarking of Sinopharm Group
- Profitable Growth rank of 7 was up compared to the prior period’s 8th rank
- This is below average performance compared to 350 large Health Care companies worldwide
- Profitability rank of 7 was worse than its Growth rank of 3
- Profitability rank of 7 was up compared to the prior period’s 8th rank
- This is below average performance compared to peers
- Growth rank of 3 was up compared to the prior period’s 5th rank
- This is above average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.